News

Generic atorvastatin recall applies to 90-count bottles of 10-mg tablets


 

More than 64,000 bottles of 10-mg generic atorvastatin tablets have been recalled, according to a notice on the Food and Drug Administration website.

The nationwide recall applies to 64,626 bottles that contain 90 tablets, and are manufactured by Ranbaxy Pharmaceuticals. The discovery of a 20-mg atorvastatin tablet in a sealed 90-count bottle of atorvastatin 10-mg tablets was the basis of the recall.

The recall is voluntary and was initiated by Ranbaxy in January 2014.

The affected bottles are pharmacy dispensing bottles, a Ranbaxy spokesperson said.

Lipitor is the brand-name version of atorvastatin.

emechcatie@frontlinemedcom.com

Recommended Reading

Endocrine Society calls for trials on testosterone’s cardiovascular effects
MDedge Family Medicine
FDA to probe saxagliptin’s heart failure risk
MDedge Family Medicine
Preterm birth linked to hyperinsulinemia in childhood
MDedge Family Medicine
Obesity at age 20 associated with increased risk of multiple sclerosis
MDedge Family Medicine
ADA backs second gestational diabetes screening option
MDedge Family Medicine
NIH and pharma partner on RA, lupus, diabetes, Alzheimer’s research
MDedge Family Medicine
Obesity epidemic overshadows rarity of pediatric T2D
MDedge Family Medicine
Thyroid cancer rise mostly overdiagnosis
MDedge Family Medicine
The future of obesity treatments could include endoscopically placed devices
MDedge Family Medicine
Curb vaccine-preventable diseases in diabetes patients
MDedge Family Medicine